Log in
EA

EVENTIDE ASSET MANAGEMENT, LLC

EVENTIDE ASSET MANAGEMENT, LLC · Investor
1Y performance ⓘ
+46%
AUM (13F)
$6.0B
# of Holdings
278
3Y performance ⓘ
+60%
vs S&P 500 ⓘ
−4%
Updated
Mar 31

EVENTIDE ASSET MANAGEMENT, LLC's EVENTIDE ASSET MANAGEMENT, LLC holds 278 U.S.-equity positions worth $6.0B (SEC 13F, Q1 2026). Top positions: Guardant Health, Inc. Common Stock 3.6%, Trane Technologies plc 2.8%, Lam Research Corp 2.4%. 13F-replication return is +60% over 3 years (-4 pts vs the S&P 500) — a replicated, non-audited figure.

Holdings

Stock% of portfolio SharesValue Latest activityAvg buy price Current priceDate
GH Guardant Health, Inc. Common Stock 3.6% 2.4M $218M ▼ 5.9% (−149K) $29.03 $161.99 (+458%) 2026-03-31
TT Trane Technologies plc 2.8% 407K $169M ▲ 0.8% (+3K) $197.26 $454.95 (+131%) 2026-03-31
LRCX Lam Research Corp 2.4% 688K $147M ▲ 2.9% (+19K) $82.10 $293.02 (+257%) 2026-03-31
MIRM Mirum Pharmaceuticals, Inc. Common Stock 2.1% 1.4M $130M ▼ 33% (−685K) $27.31 $105.95 (+288%) 2026-03-31
TRGP Targa Resources Corp. 2.1% 502K $126M ▲ 4.5% (+22K) $115.56 $270.37 (+134%) 2026-03-31
XMTR Xometry, Inc. Class A Common Stock 2.0% 3.0M $121M ▲ 0.8% (+24K) $19.34 $85.72 (+343%) 2026-03-31
GEV GE Vernova Inc. 1.9% 133K $116M ▼ 29% (−54K) $330.99 $990.29 (+199%) 2026-03-31
ODFL Old Dominion Freight Line 1.9% 592K $115M ▼ 3.1% (−19K) $169.33 $212.14 (+25%) 2026-03-31
SRRK Scholar Rock Holding Corporation Common Stock 1.8% 2.2M $108M ▼ 9.6% (−234K) $17.79 $47.30 (+166%) 2026-03-31
ARGX Argenx Se 1.5% 126K $92M ▲ 3.7% (+4K) $417.35 $853.82 (+105%) 2026-03-31
ASML Asml Hldg Nv 1.5% 68K $90M ▲ 1.9% (+1K) $701.11 $1,629.00 (+132%) 2026-03-31
IRTC iRhythm Holdings, Inc. Common Stock 1.5% 761K $90M ▲ 9.9% (+68K) $94.36 $117.17 (+24%) 2026-03-31
INSM Insmed, Inc. 1.5% 546K $89M ▲ 13% (+63K) $56.80 $98.60 (+74%) 2026-03-31
AXSM Axsome Therapeutics, Inc 1.4% 520K $88M ▼ 9.0% (−52K) $77.83 $217.99 (+180%) 2026-03-31
PCVX Vaxcyte, Inc. Common Stock 1.3% 1.4M $80M ▲ 50% (+457K) $49.73 $54.08 (+9%) 2026-03-31
ETR Entergy Corporation 1.3% 683K $77M ▲ 1.5% (+10K) $78.83 $107.62 (+37%) 2026-03-31
VST Vistra Corp. 1.2% 493K $74M ▲ 1.0% (+5K) $82.98 $148.19 (+79%) 2026-03-31
URI United Rentals, Inc. 1.2% 98K $71M ▲ 1.9% (+2K) $682.64 $1,079.26 (+58%) 2026-03-31
LBRT Liberty Energy Inc. 1.1% 2.4M $69M ▲ 22% (+433K) $20.32 $18.71 (−8%) 2026-03-31
TOST Toast, Inc. 1.1% 2.5M $66M $20.44 $32.27 (+58%) 2026-03-31
MTD Mettler-Toledo International 1.1% 51K $64M ▲ 1.0% (+493) $1,456.35 $1,416.30 (−3%) 2026-03-31
MPWR Monolithic Power Systems, Inc. 1.1% 58K $63M ▼ 15% (−10K) $662.21 $1,426.03 (+115%) 2026-03-31
RPRX Royalty Pharma plc Class A Ordinary Shares 1.0% 1.3M $63M ▲ 1.2% (+16K) $35.00 $58.43 (+67%) 2026-03-31
NVT nVent Electric plc Ordinary Shares 1.0% 524K $62M ▲ 1.7% (+9K) $45.26 $153.83 (+240%) 2026-03-31
WMB Williams Companies Inc. 1.0% 832K $61M ▲ 4.9% (+39K) $39.93 $71.54 (+79%) 2026-03-31
NDAQ Nasdaq, Inc. Common Stock 1.0% 712K $60M ▲ 0.7% (+5K) $76.00 $94.19 (+24%) 2026-03-31
GNRC GENERAC HOLDINGS INC 1.0% 307K $60M ▲ 227% (+213K) $182.99 $197.11 (+8%) 2026-03-31
BBNX Beta Bionics, Inc. Common Stock 1.0% 5.9M $60M ▲ 19% (+951K) $12.04 $12.83 (+7%) 2026-03-31
DHI D.R. Horton Inc. 1.0% 431K $59M ▲ 0.9% (+4K) $106.89 $143.06 (+34%) 2026-03-31
KLAC KLA Corporation Common Stock 1.0% 40K $58M ▼ 12% (−6K) $61.37 $182.82 (+198%) 2026-03-31
BLTE Belite Bio Inc 0.9% 358K $57M ▼ 6.6% (−25K) $116.13 $158.61 (+37%) 2026-03-31
LSCC Lattice Semiconductor Corp 0.9% 611K $57M ▼ 1.6% (−10K) $77.83 $124.27 (+60%) 2026-03-31
PLD PROLOGIS, INC. 0.9% 427K $56M ▲ 1.5% (+6K) $113.81 $144.61 (+27%) 2026-03-31
TMDX TransMedics Group, Inc. Common Stock 0.9% 549K $55M $60.87 $76.51 (+26%) 2026-03-31
DTM DT Midstream, Inc. 0.9% 402K $54M ▲ 1.8% (+7K) $111.02 $138.00 (+24%) 2026-03-31
NI NiSource Inc. 0.9% 1.1M $53M ▲ 0.9% (+10K) $40.14 $44.43 (+11%) 2026-03-31
KYMR Kymera Therapeutics, Inc. Common Stock 0.9% 627K $52M $35.21 $103.40 (+194%) 2026-03-31
RBA RB Global, Inc. 0.8% 528K $51M $90.34 $109.74 (+21%) 2026-03-31
WCN Waste Connections, Inc. 0.8% 310K $50M $139.36 $167.38 (+20%) 2026-03-31
ORLY O'Reilly Automotive, Inc. 0.8% 540K $50M $59.92 $89.35 (+49%) 2026-03-31
PWR Quanta Services, Inc. 0.8% 89K $49M ▲ 0.5% (+454) $292.92 $667.36 (+128%) 2026-03-31
COLL Collegium Pharmaceutical, Inc. Common Stock 0.8% 1.4M $47M ▼ 24% (−452K) $24.03 $35.39 (+47%) 2026-03-31
APGE Apogee Therapeutics, Inc. Common Stock 0.8% 557K $47M ▲ 28% (+121K) $77.37 $134.09 (+73%) 2026-03-31
VMC Vulcan Materials Company(Holding Company) 0.8% 170K $46M $233.79 $268.57 (+15%) 2026-03-31
NVDA NVIDIA CORP 0.7% 259K $45M ▲ 8.4% (+20K) $120.50 $200.75 (+67%) 2026-03-31
EGP EastGroup Properties Inc. 0.7% 236K $44M $176.31 $209.01 (+19%) 2026-03-31
IONS Ionis Pharmaceuticals, Inc. Common Stock 0.7% 575K $43M $70.81 $51.77 (−27%) 2026-03-31
STE STERIS plc 0.7% 195K $43M ▲ 2.2% (+4K) $209.41 $228.40 (+9%) 2026-03-31
PANW Palo Alto Networks, Inc. Common Stock 0.7% 252K $40M ▲ 73% (+106K) $132.07 $331.83 (+151%) 2026-03-31
LOW Lowe's Companies Inc. 0.7% 171K $40M $210.44 $207.81 (−1%) 2026-03-31

Showing top 50 of 278 holdings by value.

Related
GH stockTT stockLRCX stockMIRM stockAll hedge funds
FAQ

What are EVENTIDE ASSET MANAGEMENT, LLC's largest holdings?

As of the latest 13F: Guardant Health, Inc. Common Stock 3.6%, Trane Technologies plc 2.8%, Lam Research Corp 2.4%, Mirum Pharmaceuticals, Inc. Common Stock 2.1%, Targa Resources Corp. 2.1%.

How big is EVENTIDE ASSET MANAGEMENT, LLC's 13F portfolio?

$6.0B across 278 disclosed U.S.-equity positions.

What is EVENTIDE ASSET MANAGEMENT, LLC's 3-year performance?

+60% (13F-replication, price return), -4 pts vs the S&P 500. Not an audited fund return.

Where does this data come from?

U.S. SEC Form 13F-HR institutional holdings filings.

Sourced from SEC Form 13F-HR filings · Not investment advice
SEC EDGAR 13F
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.

Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.